Balyasny Asset Management LLC Guardant Health, Inc. Transaction History

Balyasny Asset Management LLC

$61.9 Billion
Q2 2025

A detailed history of Balyasny Asset Management LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 7,400 shares of GH stock, worth $688,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,400

Previous 838,992 99.12%

Holding current value

$688,348

Previous $35.7 Million 98.92%

% of portfolio

0.0%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$37.05 - $52.04 $10.2 Million - $14.3 Million	-274,644 Reduced 32.73%	564,348 $29.4 Million
Q1 2025 May 15, 2025	SELL	$31.77 - $49.94 $4.88 Million - $7.67 Million	-153,546 Reduced 15.47%	838,992 $35.7 Million
Q4 2024 Feb 14, 2025	SELL	$20.2 - $38.11 $619,715 - $1.17 Million	-30,679 Reduced 3.0%	992,538 $30.3 Million
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $22.8 Million - $37.1 Million	1,023,217 New	1,023,217 $23.5 Million
Q1 2024 May 13, 2024	SELL	$17.13 - $26.91 $5.15 Million - $8.08 Million	-300,379 Reduced 74.93%	100,519 $2.07 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $8.51 Million - $11.6 Million	-394,335 Reduced 49.59%	400,898 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $19.7 Million - $30.5 Million	761,873 Added 2283.79%	795,233 $23.6 Million
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $32.1 Million - $58.2 Million	-1,531,621 Reduced 97.87%	33,360 $1.19 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $10.6 Million - $15.6 Million	463,183 Added 42.04%	1,564,981 $36.7 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $20.3 Million - $47.8 Million	799,736 Added 264.76%	1,101,798 $30 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $7.19 Million - $10 Million	-164,698 Reduced 35.29%	302,062 $16.3 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $9.79 Million - $26.3 Million	-339,749 Reduced 42.13%	466,760 $18.8 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $15.9 Million - $33.2 Million	330,327 Added 69.37%	806,509 $53.4 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $42.2 Million - $57.3 Million	476,182 New	476,182 $47.6 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $26.8 Million - $35.8 Million	-270,947 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $29.7 Million - $44.9 Million	270,947 New	270,947 $33.6 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $24.1 Million - $34 Million	-190,022 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $15.1 Million - $20.5 Million	150,734 Added 383.66%	190,022 $24.5 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $1.08 Million - $1.5 Million	13,406 Added 51.8%	39,288 $4.39 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $1.57 Million - $2.52 Million	25,882 New	25,882 $2.1 Million

Others Institutions Holding GH

# of Institutions

425

Shares Held

127M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.51B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Guardant Health, Inc. Transaction History